Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-15-038954
Filing Date
2015-06-24
Accepted
2015-06-24 21:00:19
Documents
1
Period of Report
2015-06-22

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v413964_4.html 4  
1 OWNERSHIP DOCUMENT v413964_4.xml 4 7129
  Complete submission text file 0001144204-15-038954.txt   8387
Mailing Address
Business Address
WILLIAMS NICOLE (Reporting) CIK: 0001189006 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35668 | Film No.: 15950453

Mailing Address 450 W. 15TH STREET SUITE 505 New York NY 10011
Business Address 450 W. 15TH STREET SUITE 505 NEW YORK NY 10011 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Issuer) CIK: 0001270073 (see all company filings)

EIN.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations